AI assistant
Melexis N.V. — Earnings Release 2026
Apr 29, 2026
3975_10-q_2026-04-29_ed8cbd55-1322-4914-b069-8110a07c6257.pdf
Earnings Release
Open in viewerOpens in your device viewer
Melexis
INNOVATION WITH HEART
Press release - Regulated Information
Melexis Q1 2026 results – First quarter sales of 202.1 million EUR
Intermediate declaration by the Board of Directors
Ieper, Belgium – April 29th, 2026, 07.00 hrs CET
| CONFORM IFRS
in k EUR | Q1 2026 | Q1 2025 | YOY change
(%) | Q4 2025 | SEQ change
(%) |
| --- | --- | --- | --- | --- | --- |
| Sales | 202,094 | 198,248 | 2% | 214,493 | -6% |
| Gross result | 80,610 | 75,680 | 7% | 82,302 | -2% |
| Gross Margin | 39.9% | 38.2% | | 38.4% | |
| EBIT | 33,174 | 28,983 | 14% | 31,484 | 5% |
| EBIT in % | 16.4% | 14.6% | | 14.7% | |
| EBITDA | 45,765 | 41,257 | 11% | 44,562 | 3% |
| EBITDA in % | 22.6% | 20.8% | | 20.8% | |
| Net result | 23,094 | 24,598 | -6% | 22,575 | 2% |
| Net result per share (EPS) | 0.57 | 0.61 | | 0.56 | |
| CAPEX | 9,547 | 5,640 | | 10,770 | |
Sales for the first quarter of 2026 were 202.1 million EUR, an increase of 2% compared to the same quarter of the previous year and a decrease of 6% compared to the previous quarter. The EUR/USD exchange rate evolution had a negative impact of 4% on sales compared to the same quarter of last year and no impact on sales compared to the previous quarter.
The gross result was 80.6 million EUR or 39.9% of sales, an increase of 7% compared to the same quarter of last year and a decrease of 2% compared to the previous quarter.
R&D expenses were 14.5% of sales, G&A was at 6.8% of sales and Selling was at 2.2% of sales.
The operating result was 33.2 million EUR or 16.4% of sales, an increase of 14% compared to the same quarter of last year and an increase of 5% compared to the previous quarter.
The net result was 23.1 million EUR or 0.57 EUR per share, a decrease of 6% compared to 24.6 million EUR or 0.61 EUR per share in the first quarter of 2025 and an increase of 2% compared to the previous quarter.
Melexis Financial Press Release
Regulated Information
Melexis
INNOVATION WITH HEART
Outlook
Melexis confirms its outlook, and expects sales in the first half of 2026 to be around the same level as the previous year. Sales in the second half of 2026 are expected to grow compared to the first half of 2026.
For the first half of 2026, Melexis expects a gross profit margin around 40% and an operating margin around 17%, all taking into account a EUR/USD exchange rate of 1.17.
For the full year 2026, Melexis expects CAPEX to be around 40 million EUR.
Business update
Sales of 202.1 million EUR in the first quarter of 2026 were above the same period last year and are on track to achieve the first half 2026 sales guidance. The outperforming product lines were position sensors and pressure sensors.
Automotive applications represented 89% of total sales in the first quarter of 2026.
Melexis introduced 2 new products on the market in Q1 2026, including a high-precision inductive position sensor for safe, reliable and cost-effective operation of mechanical joints in robots and other industrial markets. We also launched our latest motor driver, which is the first of a family of products specifically designed for cooling fans for servers and data centers, and which can also be used in automotive seat ventilation.
Quote from CEO Marc Biron
"We recorded first quarter 2026 results in line with our expectations, which took into account seasonal factors and changes to incentive schemes for automotive purchases. Importantly, profitability improved already in the first quarter, based on both operational improvement and disciplined cost control.
Our automotive focus areas are designed to fully capture the structural growth trends of electrification, ADAS, and premiumization. For example, we grew customer opportunities in HVAC thermal management applications to optimize cabin temperatures with our Triphibian® pressure sensors and motor drivers for valve actuators. Opportunities also increased in ADAS for inductive and magnetic position sensors, as well as motor drivers, as the industry continues to transition toward steer-by-wire and brake-by-wire architectures. And we gained sizable new opportunities for ambient and animated LED automotive lighting.
Outside of automotive, we continue to see very strong interest in our portfolio of inductive and magnetic position sensors, and motor drivers, all to address needs for robotic joints. Together with our unique Tactaxis® technology to provide robots with the sense of touch, we are accelerating the development of physical AI to bring real world benefits."
Melexis Financial Press Release
Regulated Information
Melexis
INNOVATION WITH HEART
Financial Calendar
- Annual Shareholders Meeting May 12, 2026
- Dividend ex coupon date May 19, 2026
- Dividend record date May 20, 2026
- Dividend pay date May 21, 2026
- Publication Q2 2026 Results: July 29, 2026 (at 7 hrs CET)
- Publication Q3 2026 Results: October 28, 2026 (at 7 hrs CET)
- Publication FY 2026 Results: February 3, 2027 (at 7 hrs CET)
The company's results will be discussed in a conference call and an audio webcast on Wednesday, April 29th, 2026 at 10:30 hrs CET.
To register for the conference call (possibility to ask questions)
The conference call will be in English. You have to register for this conference call in advance. You can register by clicking here and filling out the requested information. After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes, all participants must register individually if they wish to join the call.
To register for the audio webcast (no possibility to ask questions)
You can register for the audio webcast by clicking here.
For more information:
Investors
Investor Relations
Email: [email protected]
Journalists
Brand & Communications
Email: [email protected]
About Melexis
Melexis designs, develops, and delivers edge sensor and driver solutions with a heart for people and planet. Its mission is to empower engineers to turn their ideas into applications that support the best imaginable future, one that is safe, comfortable and sustainable.
Melexis specializes in powertrain, thermal management, lighting, e-brake, e-steering and battery solutions for the automotive sector. It also expands its presence in the emerging markets of sustainable world, alternative mobility, robotics, and digital health.
Founded in 1989 in Belgium, Melexis has grown to employ around 2,000 people in 12 countries, delivering cutting-edge technology to customers worldwide.
For more information, visit www.melexis.com or follow Melexis on LinkedIn, and YouTube.
Melexis Financial Press Release
Regulated Information
Melexis
INNOVATION WITH HEART
Disclaimer
Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forward-looking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital.
Melexis Financial Press Release
Regulated Information
Melexis
INNOVATION WITH HEART
Consolidated income statement
| CONFORM IFRS
In k EUR | Quarter ended
31/3/2026 | Quarter ended
31/3/2025 | Year ended
31/12/2025
audited |
| --- | --- | --- | --- |
| Sales | 202,094 | 198,248 | 839,617 |
| Cost of sales | -121,484 | -122,568 | -515,608 |
| Gross result | 80,610 | 75,680 | 324,009 |
| R&D | -29,315 | -28,394 | -115,897 |
| G&A | -13,736 | -13,512 | -54,332 |
| Selling | -4,385 | -4,791 | -19,818 |
| Operating result (EBIT) | 33,174 | 28,983 | 133,963 |
| Financial result | -4,304 | -462 | 1,932 |
| Result before taxes | 28,869 | 28,521 | 135,895 |
| Income taxes | -5,776 | -3,923 | -23,390 |
| Net result | 23,094 | 24,598 | 112,505 |
| Net result per share in EUR | 0.57 | 0.61 | 2.78 |
Consolidated statement of financial position
| CONFORM IFRS
In k EUR | Quarter ended
31/3/2026 | Quarter ended
31/3/2025 | Year ended
31/12/2025
audited |
| --- | --- | --- | --- |
| Current Assets : | | | |
| Cash and cash equivalents | 37,139 | 34,842 | 34,633 |
| Current investments | — | — | — |
| A/R Trade | 105,457 | 101,567 | 107,852 |
| Assets for current tax | 10,650 | 14,729 | 27,727 |
| Other current assets | 101,858 | 75,740 | 108,805 |
| Inventories | 292,214 | 281,787 | 300,329 |
| Total current assets | 547,318 | 508,666 | 579,347 |
| Non-current assets : | | | |
| Property, plant and equipment | 194,850 | 205,835 | 196,956 |
| Leased assets | 7,097 | 8,133 | 7,583 |
| Intangible fixed assets | 1,729 | 1,539 | 1,197 |
| Other non-current assets | 65,123 | 143,786 | 82,819 |
| Deferred tax assets | 35,034 | 36,908 | 35,367 |
| Total non-current assets | 303,833 | 396,201 | 323,922 |
| Total assets | 851,151 | 904,867 | 903,269 |
Melexis Financial Press Release
Regulated Information
Melexis
INNOVATION WITH HEART
| CONFORM IFRS
in k EUR | Quarter ended
31/3/2026 | Quarter ended
31/3/2025 | Year ended
31/12/2025
audited |
| --- | --- | --- | --- |
| Current liabilities : | | | |
| Derivative financial instruments | 138 | 16 | 284 |
| Current portion of LT debt | 10,720 | 12,252 | 13,022 |
| Lease liabilities | 1,526 | 1,596 | 2,116 |
| A/P trade | 46,687 | 56,727 | 51,054 |
| Accrued taxes | 9,336 | 3,853 | 6,706 |
| Short-term employee benefits accruals | 27,635 | 21,665 | 22,523 |
| Other current liabilities | 6,581 | 9,198 | 5,902 |
| Deferred income | 4,439 | 3,070 | 4,445 |
| Total current liabilities | 107,062 | 108,378 | 106,052 |
| Non current liabilities : | | | |
| LT debt less current portion | 233,458 | 205,421 | 301,278 |
| Lease liabilities | 5,683 | 6,631 | 5,623 |
| Deferred tax liabilities | 2,695 | 3,660 | 2,673 |
| Other non-current liabilities | 3,115 | 4,563 | 3,115 |
| Total non current liabilities | 244,951 | 220,276 | 312,688 |
| Shareholders' equity : | | | |
| Shareholders' capital | 565 | 565 | 565 |
| Treasury shares | -59,217 | -19,387 | -50,031 |
| Legal reserve | 57 | 57 | 57 |
| Retained earnings | 539,607 | 574,606 | 427,102 |
| Current period's profit | 23,094 | 24,598 | 112,505 |
| Cumulative translation adjustment | -4,966 | -4,226 | -5,669 |
| Equity attributable to company owners | 499,138 | 576,213 | 484,529 |
| Non controlling interests | — | — | — |
| Total shareholders equity | 499,139 | 576,213 | 484,529 |
| Total liabilities, shareholders' equity and minority interests | 851,151 | 904,867 | 903,269 |
Melexis Financial Press Release
Regulated Information
Melexis
INNOVATION WITH HEART
Consolidated statement of cash flows
| CONFORM IFRS
in k EUR | Quarter ended
31/3/2026 | Quarter ended
31/3/2025 | Year ended
31/12/2025
audited |
| --- | --- | --- | --- |
| Cash flow from operating activities | | | |
| Net income | 23,094 | 24,598 | 112,505 |
| Adjustments for : | | | — |
| Operating activities | 20,713 | 18,575 | 85,266 |
| Depreciation and amortisation | 12,085 | 11,691 | 51,034 |
| Depreciation leased assets | 507 | 583 | 2,305 |
| Other provisions | — | -4 | -991 |
| Deferred income | -6 | 994 | 2,369 |
| Financial result | 2,352 | 1,388 | 7,160 |
| Income tax expense/income | 5,776 | 3,923 | 23,390 |
| Operating profit before working capital changes | 43,807 | 43,173 | 197,771 |
| A/R, Trade | 2,441 | 679 | -6,063 |
| Other current assets | 6,947 | -19,779 | -52,844 |
| Other non current assets | 17,696 | 19,796 | 80,762 |
| Inventories | 7,085 | -20,187 | -44,585 |
| A/P | -4,367 | -6,475 | -12,149 |
| Employee benefit liabilities | 5,121 | 3,459 | 4,307 |
| Other current liabilities | 679 | -122 | -3,418 |
| Cash generated from operations | 79,409 | 20,543 | 163,781 |
| Interest paid | -1,966 | -2,377 | -9,262 |
| Income tax paid | 14,388 | 874 | -28,213 |
| Cash flow from operating activities | 91,830 | 19,040 | 126,306 |
| Cash flow from investing activities | | | |
| Purchase of PPE and intangible assets (netted) | -9,526 | -5,555 | -29,364 |
| Interest received | 53 | 74 | 178 |
| Cash provided from investing activities | -9,473 | -5,481 | -29,185 |
| Cash flows from financing activities | | | |
| Proceeds/Repayment of long-and short-term debt | -70,121 | 4,351 | 100,977 |
| Repayment leasings | -551 | -545 | -2,206 |
| Dividend payment | — | — | -147,851 |
| Acquisition own shares | -9,186 | -14,977 | -45,621 |
| Cash provided from financing activities | -79,859 | -11,170 | -94,699 |
| Effect of exchange rate changes on cash and cash equivalents | 7 | -227 | -469 |
| Increase/decrease in cash and cash equivalents | 2,506 | 2,161 | 1,952 |
| Cash at beginning of the period | 34,633 | 32,681 | 32,681 |
| Cash at the end of the period | 37,139 | 34,842 | 34,633 |
Melexis Financial Press Release
Regulated Information
Melexis
INNOVATION WITH HEART
Sales per Geography
| Q1 2026 | Q1 2025 | FY 2025 | |
|---|---|---|---|
| APAC | 60% | 64% | 64% |
| Asia Pacific | |||
| EMEA | 32% | 28% | 28% |
| Europe - Middle-East - Africa | |||
| NALA | 8% | 8% | 8% |
| North America - Latin America | |||
| TOTAL | 100% | 100% | 100% |
Melexis Financial Press Release
Regulated Information